nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—obesity—gestational diabetes	0.908	1	CtDrD
Topiramate—CYP2C19—Glyburide—gestational diabetes	0.0039	0.674	CbGbCtD
Topiramate—Alcohol intolerance—Glyburide—gestational diabetes	0.00289	0.0986	CcSEcCtD
Topiramate—GRIK4—head—gestational diabetes	0.0025	0.0759	CbGeAlD
Topiramate—GRIA4—head—gestational diabetes	0.00198	0.06	CbGeAlD
Topiramate—GRIK3—vagina—gestational diabetes	0.00198	0.0599	CbGeAlD
Topiramate—Nephropathy—Glyburide—gestational diabetes	0.00193	0.0659	CcSEcCtD
Topiramate—CYP3A4—Glyburide—gestational diabetes	0.00188	0.326	CbGbCtD
Topiramate—GRIK1—vagina—gestational diabetes	0.00188	0.0569	CbGeAlD
Topiramate—GRIK5—head—gestational diabetes	0.00183	0.0554	CbGeAlD
Topiramate—GRIK3—head—gestational diabetes	0.00183	0.0554	CbGeAlD
Topiramate—GRIK1—head—gestational diabetes	0.00173	0.0526	CbGeAlD
Topiramate—GRIA3—head—gestational diabetes	0.00161	0.0489	CbGeAlD
Topiramate—CA9—islet of Langerhans—gestational diabetes	0.00159	0.0483	CbGeAlD
Topiramate—GRIK5—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00144	0.0591	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00144	0.0591	CbGpPWpGaD
Topiramate—Encephalopathy—Glyburide—gestational diabetes	0.00143	0.0489	CcSEcCtD
Topiramate—GRIA2—embryo—gestational diabetes	0.00135	0.041	CbGeAlD
Topiramate—GRIK3—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00134	0.0549	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00134	0.0549	CbGpPWpGaD
Topiramate—Coagulopathy—Glyburide—gestational diabetes	0.00118	0.0403	CcSEcCtD
Topiramate—GRIA4—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00114	0.0467	CbGpPWpGaD
Topiramate—GRIA1—adipose tissue—gestational diabetes	0.00112	0.034	CbGeAlD
Topiramate—GRIK5—Neuronal System—GLS2—gestational diabetes	0.00111	0.0453	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—GLS2—gestational diabetes	0.00111	0.0453	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—GLS2—gestational diabetes	0.00103	0.0421	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—GLS2—gestational diabetes	0.00103	0.0421	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—GLS2—gestational diabetes	0.000874	0.0358	CbGpPWpGaD
Topiramate—GRIA1—head—gestational diabetes	0.000861	0.0261	CbGeAlD
Topiramate—CA6—head—gestational diabetes	0.000861	0.0261	CbGeAlD
Topiramate—GRIA3—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000829	0.0339	CbGpPWpGaD
Topiramate—Vascular purpura—Glyburide—gestational diabetes	0.000746	0.0255	CcSEcCtD
Topiramate—Deafness—Glyburide—gestational diabetes	0.000746	0.0255	CcSEcCtD
Topiramate—Hepatic failure—Glyburide—gestational diabetes	0.000742	0.0253	CcSEcCtD
Topiramate—CA4—islet of Langerhans—gestational diabetes	0.00073	0.0221	CbGeAlD
Topiramate—Visual disturbance—Glyburide—gestational diabetes	0.000704	0.024	CcSEcCtD
Topiramate—Purpura—Glyburide—gestational diabetes	0.000692	0.0236	CcSEcCtD
Topiramate—GRIA2—head—gestational diabetes	0.000684	0.0207	CbGeAlD
Topiramate—Hypoglycaemia—Glyburide—gestational diabetes	0.000684	0.0233	CcSEcCtD
Topiramate—CA5B—adipose tissue—gestational diabetes	0.000675	0.0205	CbGeAlD
Topiramate—Hyponatraemia—Glyburide—gestational diabetes	0.00067	0.0229	CcSEcCtD
Topiramate—Diplopia—Glyburide—gestational diabetes	0.000667	0.0228	CcSEcCtD
Topiramate—GRIA3—Neuronal System—GLS2—gestational diabetes	0.000635	0.026	CbGpPWpGaD
Topiramate—SCN1A—head—gestational diabetes	0.000624	0.0189	CbGeAlD
Topiramate—GRIK2—head—gestational diabetes	0.000618	0.0187	CbGeAlD
Topiramate—CA2—islet of Langerhans—gestational diabetes	0.000605	0.0184	CbGeAlD
Topiramate—CA1—adipose tissue—gestational diabetes	0.000596	0.0181	CbGeAlD
Topiramate—CA2—embryo—gestational diabetes	0.000585	0.0178	CbGeAlD
Topiramate—Abdominal distension—Glyburide—gestational diabetes	0.000581	0.0198	CcSEcCtD
Topiramate—CA12—head—gestational diabetes	0.000577	0.0175	CbGeAlD
Topiramate—Eosinophilia—Glyburide—gestational diabetes	0.000571	0.0195	CcSEcCtD
Topiramate—Pancreatitis—Glyburide—gestational diabetes	0.000565	0.0193	CcSEcCtD
Topiramate—Sweating increased—Glyburide—gestational diabetes	0.000562	0.0192	CcSEcCtD
Topiramate—CA5B—vagina—gestational diabetes	0.000561	0.017	CbGeAlD
Topiramate—Pancytopenia—Glyburide—gestational diabetes	0.000548	0.0187	CcSEcCtD
Topiramate—SCN5A—vagina—gestational diabetes	0.000543	0.0165	CbGeAlD
Topiramate—Photosensitivity reaction—Glyburide—gestational diabetes	0.000526	0.018	CcSEcCtD
Topiramate—CA5B—head—gestational diabetes	0.000518	0.0157	CbGeAlD
Topiramate—CA9—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000506	0.0207	CbGpPWpGaD
Topiramate—SCN5A—head—gestational diabetes	0.000502	0.0152	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000496	0.0203	CbGpPWpGaD
Topiramate—GABRB2—head—gestational diabetes	0.000487	0.0148	CbGeAlD
Topiramate—GABRG2—head—gestational diabetes	0.000487	0.0148	CbGeAlD
Topiramate—Agranulocytosis—Glyburide—gestational diabetes	0.00048	0.0164	CcSEcCtD
Topiramate—CA4—adipose tissue—gestational diabetes	0.000466	0.0141	CbGeAlD
Topiramate—Hepatitis—Glyburide—gestational diabetes	0.000462	0.0158	CcSEcCtD
Topiramate—CA1—head—gestational diabetes	0.000457	0.0139	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000454	0.0186	CbGpPWpGaD
Topiramate—Visual impairment—Glyburide—gestational diabetes	0.000445	0.0152	CcSEcCtD
Topiramate—Eye disorder—Glyburide—gestational diabetes	0.000431	0.0147	CcSEcCtD
Topiramate—GABRA1—head—gestational diabetes	0.00043	0.013	CbGeAlD
Topiramate—Alopecia—Glyburide—gestational diabetes	0.000408	0.0139	CcSEcCtD
Topiramate—Erythema—Glyburide—gestational diabetes	0.000402	0.0137	CcSEcCtD
Topiramate—Malnutrition—Glyburide—gestational diabetes	0.000402	0.0137	CcSEcCtD
Topiramate—CA2—adipose tissue—gestational diabetes	0.000386	0.0117	CbGeAlD
Topiramate—GRIA1—Neuronal System—GLS2—gestational diabetes	0.00038	0.0156	CbGpPWpGaD
Topiramate—Vision blurred—Glyburide—gestational diabetes	0.000379	0.0129	CcSEcCtD
Topiramate—Tremor—Glyburide—gestational diabetes	0.000376	0.0128	CcSEcCtD
Topiramate—Anaemia—Glyburide—gestational diabetes	0.000371	0.0127	CcSEcCtD
Topiramate—Leukopenia—Glyburide—gestational diabetes	0.00036	0.0123	CcSEcCtD
Topiramate—CA4—head—gestational diabetes	0.000358	0.0108	CbGeAlD
Topiramate—CYP2C19—vagina—gestational diabetes	0.00035	0.0106	CbGeAlD
Topiramate—Convulsion—Glyburide—gestational diabetes	0.000348	0.0119	CcSEcCtD
Topiramate—GRIK2—Neuronal System—GLS2—gestational diabetes	0.000348	0.0142	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000347	0.0142	CbGpPWpGaD
Topiramate—Myalgia—Glyburide—gestational diabetes	0.000342	0.0117	CcSEcCtD
Topiramate—Arthralgia—Glyburide—gestational diabetes	0.000342	0.0117	CcSEcCtD
Topiramate—Confusional state—Glyburide—gestational diabetes	0.000331	0.0113	CcSEcCtD
Topiramate—GRIA1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.000329	0.0135	CbGpPWpGaD
Topiramate—Oedema—Glyburide—gestational diabetes	0.000328	0.0112	CcSEcCtD
Topiramate—Shock—Glyburide—gestational diabetes	0.000323	0.011	CcSEcCtD
Topiramate—Nervous system disorder—Glyburide—gestational diabetes	0.000322	0.011	CcSEcCtD
Topiramate—Thrombocytopenia—Glyburide—gestational diabetes	0.000321	0.011	CcSEcCtD
Topiramate—CA2—vagina—gestational diabetes	0.000321	0.00973	CbGeAlD
Topiramate—Hyperhidrosis—Glyburide—gestational diabetes	0.000317	0.0108	CcSEcCtD
Topiramate—Anorexia—Glyburide—gestational diabetes	0.000313	0.0107	CcSEcCtD
Topiramate—Hypotension—Glyburide—gestational diabetes	0.000306	0.0105	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000299	0.0102	CcSEcCtD
Topiramate—CA2—head—gestational diabetes	0.000296	0.00899	CbGeAlD
Topiramate—Paraesthesia—Glyburide—gestational diabetes	0.000294	0.01	CcSEcCtD
Topiramate—Dyspnoea—Glyburide—gestational diabetes	0.000292	0.00998	CcSEcCtD
Topiramate—Dyspepsia—Glyburide—gestational diabetes	0.000289	0.00985	CcSEcCtD
Topiramate—Decreased appetite—Glyburide—gestational diabetes	0.000285	0.00973	CcSEcCtD
Topiramate—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000283	0.00966	CcSEcCtD
Topiramate—Feeling abnormal—Glyburide—gestational diabetes	0.00027	0.00922	CcSEcCtD
Topiramate—Gastrointestinal pain—Glyburide—gestational diabetes	0.000268	0.00915	CcSEcCtD
Topiramate—GRIA2—Neuronal System—GLS2—gestational diabetes	0.000266	0.0109	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000261	0.0107	CbGpPWpGaD
Topiramate—Urticaria—Glyburide—gestational diabetes	0.000261	0.00889	CcSEcCtD
Topiramate—Abdominal pain—Glyburide—gestational diabetes	0.000259	0.00885	CcSEcCtD
Topiramate—CA9—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000259	0.0106	CbGpPWpGaD
Topiramate—Hypersensitivity—Glyburide—gestational diabetes	0.000242	0.00825	CcSEcCtD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—gestational diabetes	0.000241	0.00989	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000238	0.00977	CbGpPWpGaD
Topiramate—Asthenia—Glyburide—gestational diabetes	0.000235	0.00803	CcSEcCtD
Topiramate—Pruritus—Glyburide—gestational diabetes	0.000232	0.00792	CcSEcCtD
Topiramate—Diarrhoea—Glyburide—gestational diabetes	0.000224	0.00766	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00021	0.00861	CbGpPWpGaD
Topiramate—Vomiting—Glyburide—gestational diabetes	0.000209	0.00712	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000208	0.00854	CbGpPWpGaD
Topiramate—Rash—Glyburide—gestational diabetes	0.000207	0.00706	CcSEcCtD
Topiramate—Dermatitis—Glyburide—gestational diabetes	0.000207	0.00705	CcSEcCtD
Topiramate—Headache—Glyburide—gestational diabetes	0.000205	0.00701	CcSEcCtD
Topiramate—GABRB2—Neuronal System—GLS2—gestational diabetes	0.0002	0.00818	CbGpPWpGaD
Topiramate—Nausea—Glyburide—gestational diabetes	0.000195	0.00665	CcSEcCtD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—FGF2—gestational diabetes	0.000194	0.00793	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GLS2—gestational diabetes	0.000183	0.00748	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GLS2—gestational diabetes	0.00016	0.00654	CbGpPWpGaD
Topiramate—CA6—Metabolism—GGCT—gestational diabetes	0.000152	0.00621	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GGCT—gestational diabetes	0.000152	0.00621	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000149	0.00612	CbGpPWpGaD
Topiramate—CA7—Metabolism—GGCT—gestational diabetes	0.000141	0.00579	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GGCT—gestational diabetes	0.000141	0.00579	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000138	0.00567	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000138	0.00566	CbGpPWpGaD
Topiramate—CA6—Metabolism—GLS2—gestational diabetes	0.000132	0.00542	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GLS2—gestational diabetes	0.000132	0.00542	CbGpPWpGaD
Topiramate—CA12—Metabolism—GGCT—gestational diabetes	0.000131	0.00537	CbGpPWpGaD
Topiramate—CA7—Metabolism—GLS2—gestational diabetes	0.000124	0.00506	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GLS2—gestational diabetes	0.000124	0.00506	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—GCK—gestational diabetes	0.000119	0.00487	CbGpPWpGaD
Topiramate—CA12—Metabolism—GLS2—gestational diabetes	0.000115	0.00469	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000112	0.00458	CbGpPWpGaD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00011	0.00452	CbGpPWpGaD
Topiramate—CA4—Metabolism—GGCT—gestational diabetes	0.000105	0.00428	CbGpPWpGaD
Topiramate—CA2—Metabolism—GGCT—gestational diabetes	0.0001	0.0041	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—AR—gestational diabetes	9.85e-05	0.00403	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—ADIPOQ—gestational diabetes	9.79e-05	0.00401	CbGpPWpGaD
Topiramate—CA1—Metabolism—GGCT—gestational diabetes	9.61e-05	0.00393	CbGpPWpGaD
Topiramate—CA4—Metabolism—GLS2—gestational diabetes	9.14e-05	0.00374	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	9.06e-05	0.00371	CbGpPWpGaD
Topiramate—CA2—Metabolism—GLS2—gestational diabetes	8.76e-05	0.00359	CbGpPWpGaD
Topiramate—CA9—Metabolism—GGCT—gestational diabetes	8.45e-05	0.00346	CbGpPWpGaD
Topiramate—CA1—Metabolism—GLS2—gestational diabetes	8.4e-05	0.00344	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—GCK—gestational diabetes	8.36e-05	0.00342	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GGCT—gestational diabetes	8.31e-05	0.00341	CbGpPWpGaD
Topiramate—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	8.31e-05	0.0034	CbGpPWpGaD
Topiramate—CA9—Metabolism—GLS2—gestational diabetes	7.38e-05	0.00302	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NAMPT—gestational diabetes	7.26e-05	0.00297	CbGpPWpGaD
Topiramate—CA6—Metabolism—NAMPT—gestational diabetes	7.26e-05	0.00297	CbGpPWpGaD
Topiramate—CA6—Metabolism—GCK—gestational diabetes	7.21e-05	0.00295	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GCK—gestational diabetes	7.21e-05	0.00295	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ADIPOQ—gestational diabetes	6.88e-05	0.00282	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NAMPT—gestational diabetes	6.78e-05	0.00277	CbGpPWpGaD
Topiramate—CA7—Metabolism—NAMPT—gestational diabetes	6.78e-05	0.00277	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GCK—gestational diabetes	6.73e-05	0.00276	CbGpPWpGaD
Topiramate—CA7—Metabolism—GCK—gestational diabetes	6.73e-05	0.00276	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	6.72e-05	0.00275	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	6.63e-05	0.00272	CbGpPWpGaD
Topiramate—CA12—Metabolism—NAMPT—gestational diabetes	6.28e-05	0.00257	CbGpPWpGaD
Topiramate—CA12—Metabolism—GCK—gestational diabetes	6.24e-05	0.00255	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—LEP—gestational diabetes	6.08e-05	0.00249	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GCK—gestational diabetes	5.85e-05	0.0024	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	5.45e-05	0.00223	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GCK—gestational diabetes	5.35e-05	0.00219	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP19A1—gestational diabetes	5.27e-05	0.00216	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP19A1—gestational diabetes	5.27e-05	0.00216	CbGpPWpGaD
Topiramate—CA4—Metabolism—NAMPT—gestational diabetes	5.01e-05	0.00205	CbGpPWpGaD
Topiramate—CA4—Metabolism—GCK—gestational diabetes	4.97e-05	0.00204	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—gestational diabetes	4.97e-05	0.00204	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP19A1—gestational diabetes	4.92e-05	0.00202	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP19A1—gestational diabetes	4.92e-05	0.00202	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	4.81e-05	0.00197	CbGpPWpGaD
Topiramate—CA2—Metabolism—NAMPT—gestational diabetes	4.8e-05	0.00197	CbGpPWpGaD
Topiramate—CA2—Metabolism—GCK—gestational diabetes	4.77e-05	0.00195	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	4.74e-05	0.00194	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GCK—gestational diabetes	4.68e-05	0.00191	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—FGF2—gestational diabetes	4.62e-05	0.00189	CbGpPWpGaD
Topiramate—CA1—Metabolism—NAMPT—gestational diabetes	4.6e-05	0.00188	CbGpPWpGaD
Topiramate—CA1—Metabolism—GCK—gestational diabetes	4.57e-05	0.00187	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP19A1—gestational diabetes	4.56e-05	0.00187	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—LEP—gestational diabetes	4.27e-05	0.00175	CbGpPWpGaD
Topiramate—CA9—Metabolism—NAMPT—gestational diabetes	4.04e-05	0.00166	CbGpPWpGaD
Topiramate—CA9—Metabolism—GCK—gestational diabetes	4.02e-05	0.00165	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP19A1—gestational diabetes	3.64e-05	0.00149	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP19A1—gestational diabetes	3.49e-05	0.00143	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP19A1—gestational diabetes	3.34e-05	0.00137	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—gestational diabetes	3.28e-05	0.00134	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FGF2—gestational diabetes	3.25e-05	0.00133	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP19A1—gestational diabetes	2.94e-05	0.0012	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	2.89e-05	0.00118	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	2.85e-05	0.00117	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—gestational diabetes	2.81e-05	0.00115	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GGCT—gestational diabetes	2.36e-05	0.000968	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLS2—gestational diabetes	2.07e-05	0.000846	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—gestational diabetes	1.98e-05	0.00081	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.85e-05	0.000757	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GGCT—gestational diabetes	1.42e-05	0.000582	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLS2—gestational diabetes	1.24e-05	0.000509	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.13e-05	0.000464	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCK—gestational diabetes	1.13e-05	0.000461	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP19A1—gestational diabetes	8.23e-06	0.000337	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAMPT—gestational diabetes	6.81e-06	0.000279	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCK—gestational diabetes	6.77e-06	0.000277	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP19A1—gestational diabetes	4.95e-06	0.000203	CbGpPWpGaD
